Cullinan Therapeutics Inc
NASDAQ:CGEM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cullinan Therapeutics Inc
NASDAQ:CGEM
|
US |
|
ENRG Elements Ltd
ASX:BRY
|
AU |
|
G
|
GS Chain PLC
F:K85
|
UK |
|
P
|
Primoris Services Corp
NYSE:PRIM
|
US |
|
C
|
Cloudcoco Group PLC
F:GV2A
|
UK |
|
China Gas Holdings Ltd
F:EBZ0
|
HK |
|
Boxlight Corp
NASDAQ:BOXL
|
US |
|
Sumitomo Electric Industries Ltd
F:SMO
|
JP |
|
T
|
Teva Pharmaceutical Industries Ltd
BMV:TEVAN
|
IL |
|
IperionX Limited
NASDAQ:IPX
|
US |
|
B
|
Bixolon Co Ltd
KOSDAQ:093190
|
KR |
|
C
|
China Gas Holdings Ltd
XHAM:EBZ
|
HK |
|
D
|
Daeyang Electric Co Ltd
KOSDAQ:108380
|
KR |
|
Kbc Groep NV
OTC:KBCSF
|
BE |
|
LVMH Moet Hennessy Louis Vuitton SE
MIL:1MC
|
FR |
|
H
|
Heartflow Inc
NASDAQ:HTFL
|
US |
|
E
|
Ecoslops SA
F:7T0
|
FR |
|
Develop Global Ltd
ASX:DVP
|
AU |
|
L
|
Liaoning Port Co Ltd
XMUN:D7P
|
CN |
Bankruptcy Probability
Cullinan Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cullinan Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Cullinan Therapeutics Inc
NASDAQ:CGEM
|
935.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
504.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
237.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
193.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
79.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cullinan Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cullinan Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.